Study guide

7.2 Required Components of Controlled Substance Prescriptions

NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacist Licensure & Reciprocity

1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement

2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios

2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles

3 Chapter 3: Prescriptive Authority & Practitioner Categories

3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members

4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)

4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR

5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements

5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing

6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling

6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)

7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose

7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)

8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping

8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)

9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety

9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs

10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution

10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution

11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>

11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment

12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy

12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols

7.2 Required Components of Controlled Substance Prescriptions

Key Takeaways Explain This Topic AI

Under 21 CFR § 1306.05, all controlled substance prescriptions must contain 8 core elements, including patient name/address, practitioner name/address/DEA number, drug details, directions, date of issuance, and signature.

Prescriptions for controlled substances must be dated on the exact day when issued; antedating or postdating is strictly illegal under federal law.

DEA numbers follow a 9-character structure (2 letters + 7 digits) verified mathematically using the formula: Sum1 (1st+3rd+5th) + 2*(2nd+4th+6th), where the last digit of the total matches the 7th digit.

Schedule II prescriptions permit zero refills; multiple C-II prescriptions written on the same day can cover up to a 90-day supply with 'Do Not Dispense Before' annotations under 21 CFR § 1306.12.

Schedule III and IV prescriptions expire 6 months from issuance with max 5 refills, and pharmacists can never modify patient name, drug prescribed, or signature on a C-II prescription.

Last updated: July 2026

For a controlled substance prescription to be legally valid and eligible for dispensing, it must meet strict federal statutory requirements set forth in 21 CFR § 1306.05 . Pharmacists must meticulously inspect every controlled substance prescription presented—whether written, electronic, or oral—to ensure all required data elements are present and accurate prior to processing.

Mandatory Prescription Elements: 21 CFR § 1306.05

All prescriptions for controlled substances (Schedules II, III, IV, and V) must be issued on the date when signed and must bear the following mandatory elements:

Full Name and Full Residential Address of the Patient .

Full Name, Practice Address, and DEA Registration Number of the Practitioner .

Drug Name, Strength, and Dosage Form .

Quantity Prescribed (expressed numerically; many states also require written words for C-II).

Specific Directions for Use (Sig) .

Date of Issuance : Must reflect the actual date the prescription was written and signed. Antedating or postdating prescriptions is strictly prohibited under federal law.

Manual (Wet Ink) Signature or Compliant EPCS Cryptographic Signature : Rubber stamps, pre-printed signatures, or unvalidated electronic images of signatures are completely invalid.

Refill Authorizations : Explicitly stated for Schedules III, IV, and V. (Schedule II prescriptions cannot contain refills).

DEA Registration Numbers & Verification Formula

A DEA registration number is a unique 9-character alphanumeric identifier assigned by the Drug Enforcement Administration to authorized prescribers, hospitals, pharmacies, and manufacturers.

Structure of a DEA Registration Number

First Letter (Registrant Type) :

A / B / F / G : Physicians, Dentists, Veterinarians, Podiatrists, Hospitals, Pharmacies.

M : Mid-Level Practitioners (Nurse Practitioners, Physician Assistants, Optometrists, Clinical Nurse Specialists).

P / R : Manufacturers, Distributors, Researchers, Importers, Exporters, Reverse Distributors.

Second Letter : Typically corresponds to the first letter of the practitioner's last name or the first letter of the business entity name.

Seven Digits : Six random numerical digits followed by a 7th check digit .

The Mathematical DEA Verification Algorithm

On the MPJE, candidates are frequently required to verify the mathematical validity of a practitioner's DEA number using the official 4-step check-digit formula: Step 1: Add the 1st, 3rd, and 5th digits = Sum 1 \text{Step 1: Add the 1st, 3rd, and 5th digits} = \text{Sum}_1 Step 1: Add the 1st, 3rd, and 5th digits = Sum 1 ​ Step 2: Add the 2nd, 4th, and 6th digits and multiply by 2 = Sum 2 = 2 × ( 2nd + 4th + 6th ) \text{Step 2: Add the 2nd, 4th, and 6th digits and multiply by 2} = \text{Sum}_2 = 2 \times (\text{2nd} + \text{4th} + \text{6th}) Step 2: Add the 2nd, 4th, and 6th digits and multiply by 2 = Sum 2 ​ = 2 × ( 2nd + 4th + 6th ) Step 3: Total Sum = Sum 1 + Sum 2 \text{Step 3: Total Sum} = \text{Sum}_1 + \text{Sum}_2 Step 3: Total Sum = Sum 1 ​ + Sum 2 ​ Step 4: The last digit of Total Sum MUST match the 7th digit (check digit) \text{Step 4: The last digit of Total Sum MUST match the 7th digit (check digit)} Step 4: The last digit of Total Sum MUST match the 7th digit (check digit)

Detailed Numerical Example: Verifying DEA Number BS3498172

Check Registrant Type & Second Letter : 'B' indicates hospital/practitioner; 'S' corresponds to practitioner's last name (e.g., Dr. Smith).

Step 1 (Odd Positions) : 3 + 9 + 1 = 13 3 + 9 + 1 = 13 3 + 9 + 1 = 13 .

Step 2 (Even Positions × 2 \times 2 × 2 ) : ( 4 + 8 + 7 ) × 2 = 19 × 2 = 38 (4 + 8 + 7) \times 2 = 19 \times 2 = 38 ( 4 + 8 + 7 ) × 2 = 19 × 2 = 38 .

Step 3 (Total Sum) : 13 + 38 = 51 13 + 38 = 51 13 + 38 = 51 .

Step 4 (Check Digit) : The last digit of 51 51 51 is 1 1 1 . Compare to 7th digit of BS3498172 , which is 2 2 2 . Because 1 ≠ 2 1 \neq 2 1  = 2 , this DEA number is INVALID .

Institutional & Exempt Practitioners

Hospital / Institutional Registrations : Internal practitioners (residents, interns, fellow physicians) who do not possess individual DEA registrations may prescribe controlled substances under the hospital's DEA number, provided the hospital assigns a specific internal code suffix for each practitioner (e.g., AB1234567-012 ). The prescription must display the hospital DEA, internal code, printed practitioner name, and signature.

Military & Public Health Service (PHS) Practitioners : Officials of the Armed Forces, Public Health Service, or Bureau of Prisons are exempt from individual DEA registration fees. They must state their branch of service, official rank, and service identification number (often SSN) on prescriptions.

Schedule-Specific Refill & Expiration Limitations

Federal rules establish rigid boundaries for refill permissions, validity periods, and multi-prescription issuance across schedules:

Feature Schedule II (C-II) Schedule III & IV (C-III / C-IV) Schedule V (C-V)

Refills Allowed Zero (0) . Refills strictly prohibited (21 CFR § 1306.12). Maximum of 5 refills within 6 months of issuance. Allowed as authorized by prescriber (Federally; state rules may cap).

Expiration Window No federal expiration date (State laws typically enforce 14 to 90 days). Exactly 6 months from date of issuance (21 CFR § 1306.22). Federally up to 1 year (States often enforce 6 to 12 months).

Oral / Verbal Orders Allowed ONLY in emergency situations (21 CFR § 1306.11(d)). Allowed. Must be promptly reduced to writing by pharmacist. Allowed. Must be promptly reduced to writing by pharmacist.

Multiple Prescriptions Permitted up to 90-day total supply written on same date with 'Do Not Dispense Before' dates. Standard prescribing up to authorized quantity and refills. Standard prescribing up to authorized quantity and refills.

The 90-Day Rule for Multiple Schedule II Prescriptions (21 CFR § 1306.12)

An individual practitioner may issue multiple prescriptions on the same day authorizing a patient to receive a total of up to a 90-day supply of a Schedule II controlled substance, provided the following federal conditions are met:

Each prescription is written on a separate prescription blank.

Each prescription bears the actual date of issuance (e.g., Written on July 29).

The practitioner provides written instructions on each subsequent prescription indicating the earliest date on which a pharmacy may fill it (e.g., 'Do not dispense before August 28').

The practitioner determines that issuing multiple prescriptions does not create an undue risk of diversion or abuse.

The practice is fully permissible under applicable state laws.

Permissible vs. Non-Permissible Pharmacist Modifications

When a controlled substance prescription is missing information or contains minor errors, federal guidelines dictate what a pharmacist may modify after oral consultation with the prescriber:

Permissible Changes (After Direct Verbal Consultation with Prescriber)

Patient's address.

Drug strength, dosage form, and quantity prescribed.

Directions for use (sig).

Issue date (to correct an obvious clerical error, provided it is verified).

Practitioner's DEA registration number (if omitted on an otherwise valid order).

NEVER Permissible Changes (Must Obtain a Brand New Prescription)

Patient's Name .

Controlled Substance Prescribed (except for generic substitution permitted by state law).

Prescriber's Signature .

Loading diagram... DEA Registration Number Mathematical Validation Algorithm